Admission Date:  [**2135-7-7**]     Discharge Date:  [**2135-7-15**]   Service:  HISTORY OF PRESENT ILLNESS:  This is an 84-year-old woman with coronary artery disease, history of myocardial infarction, and recent cardiac catheterization, who had been experiencing increasing shortness of breath at rest.
She states that she avoids salts and she has been taking her medications regularly.
She was given Plavix on discharge, but patient discontinued Plavix after developing a severe rash within one month's time.
At the outside hospital, she received aspirin, sublingual nitroglycerin, ACE inhibitor, and started on a Heparin drip with 100 mg of Lasix and a nitroglycerin drip.
On arrival to [**Hospital1 **], the patient states that her shortness of breath had gotten better after administration of Lasix from the outside hospital.
CHEST X-RAY:  Right pleural effusion consistent with congestive heart failure.
Patient was placed on a nitroglycerin drip, Heparin drip, ACE inhibitor, statin, aspirin, and a beta blocker.
Patient was also diuresed using Lasix while on the floor.
A new in-stent stent was placed with 0% residual narrowing.
The patient was subsequently placed on Integrilin drip, Ticlid.
Subsequently, the patient received 1 unit of packed red blood cells with 20 mg of IV Lasix.
Patient was started on a Natrecor diuresis on arrival to the CCU.
Patient was on Heparin drip for prophylaxis of thrombus formation secondary to anterior akinesis visualized on echocardiogram.
In CCU the patient was started on Augmentin for presumed urinary tract infection secondary to leukocytosis of 17.
Creatinine continued to be elevated into 2.2, at which point patient's ACE inhibitor was discontinued and creatinine levels were monitored.
The patient was continued on Natrecor and Lasix combination for diuresis.
She was continued on gentle diuresis until her discharge.
The patient was getting empirically treated with Augmentin for presumed urinary tract infection.
Nitroglycerin sublingual prn.
Ranitidine 150 mg po bid.
Aspirin 325 mg po q day.
Ticlopidine 250 mg po bid for 12 months.
Atorvastatin 20 mg po q day.
Atenolol 75 mg po q day.
Folic acid 1 mg po q day.
Imdur 30 mg po q day.
Augmentin 500-125 mg tablets po q day for three days postdischarge.
Coumadin 3 mg po q day.
She was encouraged to see her primary care physician regarding her creatinine levels, her INR, and restarting ACE inhibitor as an outpatient.
